Aims/hypothesis Previous meta-analyses have suggested that diabetes confers a greater excess risk of coronary heart disease, stroke, vascular dementia, and heart failure in women …
Background The prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with coronary artery disease (CAD) with different glucose status has not been …
AH Johnson, LA Stock, BM Petre… - JAAOS-Journal of the …, 2023 - journals.lww.com
Methods: The TriNetX Research Network database was queried for patients undergoing elective orthopaedic surgeries from April 2020 to January 2022 in the following …
Lower extremity peripheral artery disease, or often simply called peripheral artery disease (PAD), is a common cardiovascular disease, as coronary artery disease is. Atherosclerotic …
M Takahara, Y Soga, O Iida - European Heart Journal, 2024 - academic.oup.com
Abstract Background and Aims Patients undergoing revascularization for lower extremity arterial disease (LEAD) may face a higher risk of mortality than those with coronary artery …
Y Miao, Y Wang, Y Wang, P Yan, Z Chen… - … Syndrome and Obesity, 2024 - Taylor & Francis
Background Lower extremity peripheral artery disease (LEAD) is a significant chronic complication of type 2 diabetes mellitus (T2DM) that significantly contributes to disability and …
X He, J Su, X Ma, W Lu, W Zhu, Y Wang, Y Bao… - Cardiovascular …, 2020 - Springer
Background Clinical and basic investigations have indicated a significant association between circulating growth differentiation factor 15 (GDF15) and cardiovascular disease; …
Ž Reiner, J De Sutter, L Ryden, E Mirrakhimov… - International Journal of …, 2021 - Elsevier
Background and aim Peripheral artery disease (PAD) is associated with an increased risk of fatal and non-fatal coronary heart disease (CHD). The aims of the this study were 1) to …
E Takematsu, M Massidda, G Howe, J Goldman… - Scientific Reports, 2024 - nature.com
Therapies to revascularize ischemic tissue have long been a goal for the treatment of vascular disease and other disorders. Therapies using stem cell factor (SCF), also known as …